My Green Doctor
MAY 3, 2025
The Department of Energy’s Energy.gov – Enhanced Community Resilience : Clinics powered by renewable energy are better equipped to maintain operations during power outages, ensuring uninterrupted patient care during emergencies. The product manufacturers and vendors will need to be active partners as well. 3 “Each U.S.
FDA Law Blog
OCTOBER 6, 2021
By Faraz Siddiqui — Last week, we blogged about a growing list of drug manufacturers that have refused to follow a 2010 guidance issued by the Health Resources and Services Administration (“HRSA”), which permits 340B covered entities to contract with multiple pharmacies to dispense drugs to covered entity patients. Code Ann.§
FDA Law Blog
OCTOBER 24, 2024
Gibbs — A recent blog post focused on the potentially negative implications of the proposed Patent Eligibility Restoration Act (PERA) for manufacturers of generic drugs and biosimilar products. By 2010, about 2000 isolated human genes had been patented in the U.S. Javitt & Jeffrey N. Cook-Deegan et al.
Expert insights. Personalized for you.
52 
Let's personalize your content